LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver ...

Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated ...

GSK’s bepirovirsen accepted for regulatory review in Japan as a potential first-in-class treatment for chronic hepatitis B: London, UK Friday, February 27, 2026, 09:00 Hrs [IST] ...

Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2025.

National data show rates dropped more than 10 points in 2 years after 2023 peak ...

Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated Mid-2026 BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuti ...

The presentations can be found on the Posters & Presentations section of the Aligos website ( www.aligos.com) after the live event.

A review published in Infection highlights viral mimic systems that safely replicate key features of pathogens like SARS-CoV-2. These technologies allow vaccine testing in lower-level biosafety ...

Liver disease often develops silently, with early signs like persistent fatigue, slow metabolism, and increasing belly fat ...

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

Morocco’s Ministry of Health and Social Protection has confirmed that no epidemic outbreaks have been recorded following the exceptional floods that recently hit the city of Ksar El Kebir and the ...

Doctors say that fatty liver disease has become a leading indication for transplantation in India.